Alejandro Martín García-Sancho

All papers authored by Alejandro Martín García-Sancho

Distributing this paper is prohibited by the publisher

2022 Mahmoud Elsawy, Julio C. Chavez, Irit Avivi, Jean-François Larouche, Luciano Wannesson, Kate Cwynarski, Keren Osman, Kelly Davison, Jakob D. Rudzki, Saurabh Dahiya, Kathleen Dorritie

, Samantha Jaglowski

, John Radford

, Franck Morschhauser

, David Cunningham

and 16 other authors

Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma

Upload

This paper is made freely available by the publisher.

Franck Morschhauser

, Loretta Nastoupil

, Pierre Feugier, Jean-Marc Schiano de Colella

, Hervé Tilly, Maria Lia Palomba

, Emmanuel Bachy

, Edward N. Libby, Rene-Olivier Casasnovas

, Christophe Fruchart, Loic Ysebaert

, Ian W. Flinn

, Schiano de Colella Jm, Hervé Maisonneuve, Nancy L. Bartlett

and 27 other authors

Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R²) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma

Download from doi.org

Gloria Iacoboni

, Jaap A. van Doesum

, Michiel van Aalderen, Tom van Meerten, Kai Rejeski, Guillermo Villacampa

, Annalisa Chiappella

, Francesca Bonifazi, Serafina Guadagnuolo, Lucia Lopez-Corral

, Lucía López Corral, Mariana Bastos-Oreiro, Nuria Martínez-Cibrian, Javier Delgado Serrano, Stefania Bramanti and 12 other authors

Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma

Download from ashpublications.org

Emmanuel Bachy

, Vincent Camus

, Catherine Thieblemont

, David Sibon

, René-Olivier Casasnovas

, Loïc Ysebaert

, Gandhi Damaj, Stéphanie Guidez, Gian Matteo Pica, Won Seog Kim

, Soon Thye Lim, Marc André, Alejandro Martín García-Sancho

, Maria Jesus Penarrubia

, Philipp B. Staber

and 11 other authors

Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)

Download from doi.org

2021 Carlos Jiménez-Cortegana, Pilar M. Sánchez-Martínez, Natalia Palazón-Carrión, Esteban Nogales-Fernández, Fernando Henao-Carrasco, Alejandro Martín García-Sancho

, Antonio Rueda, Mariano Provencio

, Luis de la Cruz-Merino, Víctor Sánchez-Margalet

Lower Survival and Increased Circulating Suppressor Cells in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma with Deficit of Vitamin D Levels Using R-GDP Plus Lenalidomide (R2-GDP): Results from the R2-GDP-GOTEL Trial

Download from doi.org

Sophie Bernard, Herve Ghesquieres, Rene-Olivier Casasnovas, Samuel Griolet

, Maria Gomes da Silva

, Pierre Feugier, Franck Morschhauser, Judith Trotman

, Loic Renaud

, Richard Greil

, Alejandro Martín García-Sancho, Sebastian Grosicki

, Koen van Eygen

, Christiane Copie-Bergman, Corinne Haioun and 1 other authors

Incidence of central nervous system relapses in patients with DLBCL treated with lenalidomide as maintenance after R-CHOP

Download from doi.org

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2020 Cecilia Carpio, Reda Bouabdallah, Loïc Ysebaert, Juan-Manuel Sancho, Gilles Andre Salles

, Raul Cordoba, Antonio Pinto, Mecide Gharibo, Drew Rasco, Carlos Panizo

, Jose A. Lopez-Martin, Armando Santoro, Antonio Salar, Silvia Damian

, Alejandro Martin Garcia-Sancho

and 17 other authors

Avadomide monotherapy in relapsed/refractory DLBCL: Safety, efficacy, and a predictive gene classifier

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Alejandro Martín García-Sancho